影响因子:2.517
ISSN:0969-8051
出版社:Elsevier
出版地:Philadelphia
出版国家:United States
刊期:双月刊
创刊时间:1993
语种:英文
审稿周期:一般,3-8周
中科院分区:3
投稿命中率:命中率约30.90%容易
国外数据收录:IMIM
中国收录文章数:36
5年影响因子:2.572
研究领域:放射核医学
Nuclear Medicine and Biology is intended for original research contributions describing original synthesis, in vitro tissue studies, or in vivo use of radiotracers, radiopharmaceuticals, or therapeutic agents. Papers concentrate on the synthesis, testing in vitro, and examination of a compound in vivo. Extensive studies proving the mechanism of localization in vivo whether the radioactive substance is based on receptor-, enzyme-, or tumor antigen-binding or other well defined processes are an integral part of each evaluation. Additionally, studies should define a significant compound that is a sensitive probe of a biochemical change in vivo.
同领域期刊名称 | 影响因子 |